Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AstraZeneca PLC - American Depositary Shares (NQ:AZN)

77.94 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 49,358
Open 77.94
Bid (Size) 77.85 (13)
Ask (Size) 77.90 (15)
Prev. Close 77.94
Today's Range 77.94 - 77.94
52wk Range 61.24 - 87.67
Shares Outstanding N/A
Dividend Yield 2.69%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Specter of Stagflation: Trump's Tariffs Cast a Long Shadow Over the U.S. Economy
Economists and investors are increasingly sounding the alarm over the growing risk of "stagflation," a perilous economic phenomenon characterized by high inflation coupled with stagnant economic... 
Via MarketMinute
Topics Economy Government Supply Chain
Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca Face Renewed Claims Of Conspiring To Restrict 340B Discounts
A federal appeals court revived a lawsuit accusing Sanofi, Eli Lilly, Novo Nordisk, and AstraZeneca of conspiring to restrict 340B drug discounts for safety-net clinics, sending the case back to... 
Via Benzinga
Topics Lawsuit

Performance

YTD
+18.3%
+18.3%
1 Month
+8.6%
+8.6%
3 Month
+17.7%
+17.7%
6 Month
+4.7%
+4.7%
1 Year
-6.5%
-6.5%

More News

Read More
Stagflation Specter Haunts Markets as Economic Data Disappoints
Via MarketMinute
Topics Economy Stocks World Trade
1 Small-Cap Biotech Stock Poised for a Breakout
Via The Motley Fool
Topics Economy
Moderna, Pfizer, Sanofi In Focus As US Winds Down mRNA Vaccine Plans; Retail Turns Bearish On AstraZeneca
Via Stocktwits
EXCLUSIVE: Vivani Prioritizes Semaglutide-Based Implant After Promising Preclinical Data
Via Benzinga
Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'
Via Benzinga
Topics Government
AstraZeneca CEO Calls US Drug Pricing Model ‘Unsustainable’ — Pushes for Global Rate Alignment
Via Stocktwits
AstraZeneca Q2 Beats On Cancer Drug Sales, Maintains Guidance — Shares Rise Premarket As Retail Cheers
Via Stocktwits
Earnings Scheduled For July 29, 2025
Via Benzinga
AstraZeneca Earnings Preview
Via Benzinga
Trump Turns Up Heat On Big Pharma CEOs To Slash Drug Prices Within 60 Days — But Retail Traders Don't Flinch
Via Stocktwits
Topics Government
Why AstraZeneca Stock Was Topping the Market on Tuesday
Via The Motley Fool
AstraZeneca Q2 Sales Beat Estimates On Strong Cancer Drugs Revenues, Reaffirms 2025 Outlook
Via Benzinga
Topics Earnings
AstraZeneca results: H1 and Q2 2025
From AstraZeneca
Via Business Wire
Why Is Micro-Cap AIM ImmunoTech Stock Surging?
Via Benzinga
IMFINZI® (durvalumab) granted Priority Review and Breakthrough Therapy Designation in the US for patients with resectable early-stage gastric and gastroesophageal junction cancers
From AstraZeneca
Via Business Wire
5 Dividend Stocks to Hold for the Next 20 Years
Via The Motley Fool
AstraZeneca Prepares Showdown With JNJ, Amgen With Phase 3 Win For Myasthenia Gravis Drug Candidate
Via Benzinga
What's Driving the Market Sentiment Around AstraZeneca?
Via Benzinga
Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US
Via Benzinga
Topics Government
Sanofi Expands Respiratory Vaccine Portfolio With UK Biotech Buy
Via Benzinga
Dow Futures Edge Lower As Investors Exercise Caution After S&P 500’s Record High: GM, KO, NXPI, AZN Among Stocks To Watch
Via Stocktwits
Topics ETFs Government Stocks
AstraZeneca Bets Big On America With $50B Investment, New Virginia Hub Plans Amid Pharma Tariff Jitters
Via Stocktwits
Topics Artificial Intelligence Government World Trade
AstraZeneca's Multi-Billion Dollar Cancer Drug Tagrisso Improves Overall Survival In Patients With Advanced Lung Cancer
Via Benzinga

Frequently Asked Questions

Is AstraZeneca PLC - American Depositary Shares publicly traded?
Yes, AstraZeneca PLC - American Depositary Shares is publicly traded.
What exchange does AstraZeneca PLC - American Depositary Shares trade on?
AstraZeneca PLC - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for AstraZeneca PLC - American Depositary Shares?
The ticker symbol for AstraZeneca PLC - American Depositary Shares is AZN on the Nasdaq Stock Market
What is the current price of AstraZeneca PLC - American Depositary Shares?
The current price of AstraZeneca PLC - American Depositary Shares is 77.94
When was AstraZeneca PLC - American Depositary Shares last traded?
The last trade of AstraZeneca PLC - American Depositary Shares was at 08/13/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.